Clinical Trial Update: Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI) [NA]

View source ↗

Summary

A completed clinical trial evaluated the safety and efficacy of piracetam taken for 12 months in people with mild cognitive impairment. The sponsor of the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Piracetam (piracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Memory Disorders | NA | Status: COMPLETED